2025 Chinese guideline for the management of cardiomyopathies(reprinted)
The Cardiomyopathy Specialty Alliance of National Center for Cardiovascular Diseases
Cardiovascular Precision Medicine Branch of China International Exchange and Promotive Association for Medical and Health Care
Song Lei
Hui Rutai
Abstract：Cardiomyopathy is a group of myocardial disorders that are clinically common and characterized by complex etiologies,heterogeneous clinical manifestations,adverse prognoses and strong associations with genetics.In recent years,significant advances and breakthroughs have been achieved in its definition,classification,precise diagnosis,and individualized treatment.This guideline integrates the latest evidence,systematically elucidates the definition,classification,etiologies and pathogenesis of various types of cardiomyopathy,and offers recommendations for diagnosis,treatment and management,with the aim to improve the clinical practice level of cardiomyopathy in China.
Keywords：CardiomyopathyClassificationGenetic testingDiagnosis and treatmentManagement
Publication Date：2025-05-20
Online Publishing Date：2025-11-20(First online date of this platform, not the publication date of the document)
Pages：42( 7-48 )